MedPath

The effectiveness of cognitive-behavioral therapy (CBT) on positive and negative psychotic symptoms and emotional regulation in patients with schizophrenia spectrum disorders

Not Applicable
Conditions
Schizophrenia spectrum disorders.
Schizophrenia
Registration Number
IRCT20210412050937N2
Lead Sponsor
niversity of social welfare and rehabilitation sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
5
Inclusion Criteria

Diagnosis of schizophrenia spectrum disorders based on DSM5 criteria
Relative control of acute symptoms of patients
Average age 18 to 45 years
Voluntary attendance with informed written consent Research
Having a minimum education with a diploma certificate
Receiving a higher score on PANSS and DERS scales Compared to other patients
Patients who have been in the ward for at least one week

Exclusion Criteria

No criminal or judicial problems
Alcohol or substance abuse
Neurological disorders such as epilepsy, stroke or severe concussion
High levels of disordered behavior or high risk of suicide or homicide
Diagnosis Mental retardation.
Severe learning disability

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Positive and negative psychotic symptom score in Schizophrenia positive and negative symptom scale. Timepoint: Measures of The Positive and Negative Psychotic Symptoms two weeks before the start of the intervention (three baseline), all intervention sessions (16 Sessions), and 3 months after the end of the intervention (three follow-up lines). Method of measurement: The Positive and Negative Psychotic Symptoms Scale.;Emotional regulation score in the Gratz and Roemer Emotional Regulation Difficulties Scale. Timepoint: Measures of emotional regulation two weeks before the start of the intervention (three baseline), all intervention sessions (16 sessions), and 3 months after the end of the intervention (three follow-up lines). Method of measurement: Gratz and Roemer Emotional Regulation Difficulties Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath